Literature DB >> 11103360

Ongoing issues in pneumonia care: when to admit, how to treat and the role of oral therapy.

A C Shillington1.   

Abstract

In recent decades the understanding of the diagnosis and treatment of community acquired pneumonia (CAP) has increased within the medical scientific community. The challenge remains how best to disseminate new information to the practicing clinician to facilitate improved outcomes and cost-effective care. To accomplish this end, professional organizations such as the Infectious Disease Society of America (IDSA) and the American Thoracic Society (ATS) have developed and published consensus guidelines reflecting the proposed standard of medical care. Three ongoing areas of ambiguity and divergence between published guidelines and clinical practice include treatment selection, the admission decision, and the utility and role of oral therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11103360     DOI: 10.1023/a:1005544309314

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  16 in total

1.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

2.  Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia.

Authors:  P P Gleason; W N Kapoor; R A Stone; J R Lave; D S Obrosky; R Schulz; D E Singer; C M Coley; T J Marrie; M J Fine
Journal:  JAMA       Date:  1997-07-02       Impact factor: 56.272

3.  Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America.

Authors:  J G Bartlett; R F Breiman; L A Mandell; T M File
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

4.  Pharmacist-managed intravenous to oral step-down program.

Authors:  K A Hunter; G K Dormaier
Journal:  Clin Ther       Date:  1995 May-Jun       Impact factor: 3.393

5.  Treatment of community-acquired pneumonia--IDSA guidelines. Infectious Diseases Society of America.

Authors:  J M Bernstein
Journal:  Chest       Date:  1999-03       Impact factor: 9.410

6.  Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes?

Authors:  D McCormick; M J Fine; C M Coley; T J Marrie; J R Lave; D S Obrosky; W N Kapoor; D E Singer
Journal:  Am J Med       Date:  1999-07       Impact factor: 4.965

7.  Identification of low-risk hospitalized patients with pneumonia. Implications for early conversion to oral antimicrobial therapy.

Authors:  S R Weingarten; M S Riedinger; G Varis; M S Noah; M J Belman; R D Meyer; A G Ellrodt
Journal:  Chest       Date:  1994-04       Impact factor: 9.410

8.  Uncomplicated pneumonia: an evaluation of determinants of length of hospitalization.

Authors:  S Weitzman; D Heimer; L Naggan; G Bar-Ziv; S Glick
Journal:  Isr J Med Sci       Date:  1983-07

9.  Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial.

Authors:  S J Atlas; T I Benzer; L H Borowsky; Y Chang; D C Burnham; J P Metlay; E A Halm; D E Singer
Journal:  Arch Intern Med       Date:  1998-06-22

10.  The effects of patient, hospital, and physician characteristics on length of stay and mortality.

Authors:  L R Burns; D R Wholey
Journal:  Med Care       Date:  1991-03       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.